期刊文献+

食管癌P53基因第5外显子突变分析 被引量:1

Analysis on p53 gene exon 5 mutations in esophageal cancer
下载PDF
导出
摘要 目的 分析不同地区食管癌组织中 p5 3基因第 5外显子的突变谱。 方法 采用PCR扩增产物纯化后直接DNA序列测定技术对陕西省西安市 4 2例和河南省林州市 4 3例食管癌标本 p5 3基因第 5外显子突变情况进行检测。结果 西安和林州市食管癌标本中 p5 3基因第 5外显子突变率分别为 14 3% (6 /42 )和 18 6 % (9/43) ,两地突变率比较差异无统计学意义 (P >0 0 5 )。西安 6个突变位点中 4个为点突变 ,2个为缺失突变 ;林州 10个突变位点中9个为点突变 ,1个为插入突变。西安市有 4例突变发生在 12 6~ 12 8位点 ,林州市仅有 2例发生在该区域 (2 /10 ) ,但两者相比差异无统计学意义 (P >0 0 5 )。结论 西安市食管癌 p5 3基因第 5外显子的突变位点相对集中 ,林州市突变位点比较分散 ,可能与该地区多种危险因素的暴露有关。 Objective To analyze p 53 gene exon 5 mutations in esophageal cancer (EC) specimens in Xi'an city and Linzhou city.Methods Polymerase chain reaction (PCR) direct sequencing technique was used to detect the alteration of p 53 gene exon 5 for EC specimens from Xi'an city and Linzhou city.Results Mutation rate of p 53 gene exon 5 mutation in Xi'an and Linzhou EC specimens were 14 3%(6/42) and 18 6%(9/43) respectively, which were not significantly different ( P >0 05).Point mutation was the main mutation type.In Xi'an EC specimens, there were six mutation sites including 4-point mutation and 2 base deletions.In Linzhou EC specimens,there were 10 mutation sites,including 9-point mutation and 1 insert mutation.In Xi'an p 53 gene exon 5 mutations were in 126 to 128 bases (4/6),while in Linzhou EC specimens only two had mutations in thiese sites.But these distributions of mutation sites were not significantly different ( P >0 05).Conclusion The p 53 gene exon 5 mutation sites in Xi'an were relatively concentrated;in Linzhou were relatively scattered in different codes,which might be owing to the great variety of risk factors in this district.
出处 《中国公共卫生》 CAS CSCD 北大核心 2005年第3期288-289,共2页 Chinese Journal of Public Health
关键词 P53基因 食管癌 突变 p53 gene esophageal carcinoma mutation
  • 相关文献

参考文献7

  • 1Lu SH.Alterations of oncogenes and tumor suppressor genes in esophageal cancer in China[J].Mutation Res,2000,462:343-353.
  • 2Montesano R,Hollstein M and Hainaut P.Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis:A review[J].Int J Cancer,1996,69:225-235.
  • 3Lam KY,Tsao SW,Zhang DK,et al.Prevalence and predictive value of P53 mutation in patients with oesophageal squamous cell carcinomas:A prospective clinico-pathological study and survival analysis of 70 patients[J].Int J Cancer,1997,74:212-219.
  • 4Nan H,Huang J,Michael R,et al.Frequent inactivation of the TP53 gene in squamous cell carcinoma from a high-risk population in China[J].Clin Cancer Res,2001,7:883-891.
  • 5Biramijamal F,Allameh A,Mirbod P,et al.Unusual profile and high prevalence of P53 mutation in esophageal squamous call carcinomas from Northern Tran[J].Cancer Res,2001,61:3119-3123.
  • 6Lung ML,Chan WC,Zong YS,et al.p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China[J].Cancer Epidemiol Biomarkers Prev,1996,5(4):277-284.
  • 7Hussain SP,Harris CC.Molecular epidemiology and carcinogenesis:endogenous and exogenous carcinoges[J].Mutat Res,2000,462:311-322.

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部